Skip to main content
. 2025 Aug 23;151(8):235. doi: 10.1007/s00432-025-06289-5

Table 2.

Incidence and EORCT classification of invasive fungal diseases by prophylaxis group

Incidence of IFD Overall (n = 95) L-AMB (n = 34) Posaconazol (n = 37) Micafungin (n = 24)
overall 14 10 4 0
Possible 4 4 0 0
Probable 7 5 2 0
Proven 3 1 2 0

IFD invasive fungal disease, L-AMB liposomal amphotericin B